URGN UroGen Pharma Ltd.
Nasdaq · SEC CIK 1668243 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $4.73M 11 sales by 3 insiders
- Filings on record
- 119 since 2021-07-12, latest 2026-09-09 14:37
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Schoenberg Mark | Chief Medical Off | — | $4.48M |
| Smith Jason Drew | GC | — | $211.9K |
| Degnan Chris | CFO | — | $37.1K |
| Wildman Daniel George | Dir | — | — |
| WEN LEANA | Dir | — | — |
| Holden Stuart | Dir | — | — |
| Robinson James A. Jr. | Dir | — | — |
| BUTITTA CYNTHIA M | Dir | — | — |
Transactions 107
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-28 | 2021-10-26 | URGN | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +208 | 21.7K | +1.0% | — |
| D | 2021-08-03 | 2021-07-31 | URGN | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +500 | 21.7K | +2% | — |
| D | 2021-08-03 | 2021-08-02 | URGN | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $15.64 | -243 | 21.5K | -1% | -$3,801 |
| D | 2021-07-28 | 2021-07-26 | URGN | Schoenberg Mark | Chief Medical Off | M - OptEx | — | -208 | 20.9K | -1.0% | — |
| D | 2021-07-28 | 2021-07-26 | URGN | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $15.30 | -103 | 20.8K | -0.5% | -$1,576 |
| DMA | 2021-07-12 | 2020-06-03+ | URGN | Barrett Elizabeth A. | CEO | M - OptEx | — | +61.7K | 166.3K | +59% | — |
| DMA | 2021-07-12 | 2020-02-03+ | URGN | Barrett Elizabeth A. | CEO | M - OptEx | — | +35.2K | 131.0K | +37% | — |
Purchase Sale Sale after option exercise All abbreviations